文献速递心律失常血脂与心血管预防

不同临床特征的低危房颤患者血栓栓塞风险

[The thromboembolism risk of low-risk atrial fibrillation patients with different clinical characteristics].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2020-01-01

该前瞻性队列研究纳入中国房颤注册研究中2 862例CHA2DS2-VASc评分低危的非瓣膜性房颤患者,随访中位1.5年,整体血栓栓塞年化发生率为0.57%。CHA2DS2-VASc评分2分组及其中65~74岁女性患者的血栓栓塞风险显著高于0分组,提示对该类患者可能需要更积极的口服抗凝治疗。

要点

  • 低危房颤患者整体血栓栓塞年化发生率为0.57%。
  • CHA2DS2-VASc评分2分组血栓栓塞风险显著高于0分组(HR=3.53)。
  • 65~74岁女性评分2分患者风险更高(HR=2.67),可考虑积极抗凝。

核心结论

  • 低危房颤患者中,CHA2DS2-VASc评分2分者尤其是65~74岁女性血栓栓塞风险较高,可能需要更积极地考虑口服抗凝治疗。

研究设计与样本

  • 前瞻性队列研究,连续纳入中国房颤注册研究2011年8月至2018年12月2 862例CHA2DS2-VASc评分低危(男性0或1分,女性1或2分)的非瓣膜性房颤患者。

主要发现

  • 随访中位1.5年(5 811.82人年)共发生33例血栓栓塞事件,整体年化发生率为0.57%(95%CI 0.40%~0.80%)。
  • CHA2DS2-VASc评分0、1、2分组的血栓栓塞事件数分别为8、11、14例,年化发生率分别为0.40%(95%CI 0.20%~0.81%)、0.39%(95%CI 0.22%~0.71%)和1.34%(95%CI 0.80%~2.27%)。
  • CHA2DS2-VASc评分2分组血栓栓塞风险显著高于0分组(HR=3.53,95%CI 1.48~8.44,P=0.005)。
  • 评分2分组中65~74岁女性血栓栓塞风险显著高于0分组(HR=2.67,95%CI 1.63~4.38,P<0.001)。

关键数值与推荐

  • 低危定义:CHA2DS2-VASc评分男性0或1分,女性1或2分。
  • CHA2DS2-VASc评分2分组较0分组血栓栓塞风险HR=3.53(95%CI 1.48~8.44,P=0.005)。
  • 评分2分组中65~74岁女性较0分组血栓栓塞风险HR=2.67(95%CI 1.63~4.38,P<0.001)。

临床怎么用

  • 对CHA2DS2-VASc评分2分的低危房颤患者,尤其65~74岁女性,应加强血栓栓塞风险评估。
  • 该类患者可能需要更积极地考虑口服抗凝治疗以降低血栓栓塞风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: This study explored the thromboembolism risk of low-risk atrial fibrillation (AF) patients (CHA2DS2-VASc score of 0 or 1 for male and 1 or 2 for female) with different clinical characteristics to provide the basis for anticoagulation decision-making in these patients. Methods: We prospectively enrolled consecutive 2 862 nonvalvular low-risk AF patients between August 2011 to December 2018 in China-AF (China Atrial Fibrillation Registry) Study, their CHA2DS2-VASc score was 0 or 1 for male and 1 or 2 for female. According to their age, sex, presence or absence of hypertension, diabetes mellitus, congestive heart failure, and vascular disease at the time of enrolling, patients were divided into CHA2DS2-VASc score 0 score group, 1 score group, and 2 score group. Patients were followed up every 6 months by outpatient clinic visit or telephone interview. The outcome was a thromboembolic event, including ischemic stroke and systemic embolism. Univariate Cox regression analysis was used to compare the thromboembolism risk between the patients with different risk factors and CHA2DS2-VASc score 0 group. Results: A total of 2 862 low-risk atrial fibrillation patients were enrolled in this study. 915 patients (32.0%) were female, and age was (55.0±10.7) years old. There were 933 patients (32.6%) in CHA2DS2-VASc score 0 group, 1 401 patients (49.0%) in score 1 group and 528 patients (18.5%) in score 2 group. During follow-up (median 1.5 years, 5 811.82 person-years), 33 cases of thromboembolic events were recorded, the annual rate of thromboembolism was 0.57% (95%CI 0.40%~0.80%). The number of thromboembolic events in patients with CHA2DS2-VASc score 0, 1 and 2 were 8, 11 and 14, respectively, and the annual thromboembolism event rates were 0.40% (95%CI 0.20%-0.81%), 0.39% (95%CI 0.22%-0.71%) and 1.34% (95%CI 0.80%-2.27%), respectively. The risk of thromboembolism of CHA2DS2-VASc score 2 group (HR=3.53, 95%CI 1.48-8.44; P=0.005), especially female patients aged 65-74 years in CHA2DS2-VASc score 2 group (HR=2.67, 95%CI 1.63-4.38; P<0.000) was significantly higher than that in patients of CHA2DS2-VASc score 0 group. Conclusion: Low-Risk Atrial Fibrillation patients with CHA2DS2-VASc score 2, especially female patients aged 65-74 years old with CHA2DS2-VASc score 2 are at higher risk of thromboembolism in low-risk AF patients. For such patients, intensified oral anticoagulant therapy might be helpful to reduce the risk of thrombolism. 目的: 探讨不同临床特征低危心房颤动(房颤)患者(CHA2DS2-VASc评分男性≤1分,女性≤2分)的血栓栓塞风险,并为该类患者的抗凝决策提供依据。 方法: 前瞻性地连续入选2011年8月至2018年12月中国房颤注册研究中CHA2DS2-VASc评分男性≤1分,女性≤2分的非瓣膜性房颤患者。根据患者基线年龄、性别,以及合并高血压、糖尿病、慢性心力衰竭和血管疾病的情况,将其分为CHA2DS2-VASc评分0分组、1分组和2分组。所有患者每6个月电话或门诊随访1次,终点事件为包括缺血性卒中和系统性栓塞在内的血栓栓塞事件。计算血栓栓塞事件的年化发生率,并采用单因素Cox回归分析比较合并不同危险因素的房颤患者与CHA2DS2-VASc评分0分组之间血栓栓塞风险的差异。 结果: 共纳入2 862例低危房颤患者,女性915例(32.0%),年龄(55.0±10.7)岁。CHA2DS2-VASc评分0分组933例(32.6%),1分组1 401例(49.0%),2分组528例(18.5%)。随访期间(中位随访1.5年,共5 811.82人年)共发生33例血栓栓塞事件,整体年化发生率为0.57%(95%CI 0.40~0.80)。其中CHA2DS2-VASc评分0、1及2分组患者的血栓栓塞事件数分别为8、11及14例,年化发生率分别为0.40%(95%CI 0.20~0.81)、0.39%(95%CI 0.22~0.71)及1.34%(95%CI 0.80~2.27)。CHA2DS2-VASc评分2分组(HR=3.53,95%CI 1.48~8.44,P=0.005)及其中年龄65~74岁的女性患者(HR=2.67,95%CI 1.63~4.38,P<0.001)的血栓栓塞风险显著高于CHA2DS2-VASc评分0分组。 结论: 低危房颤患者中,年龄65~74岁的女性血栓栓塞风险较高,对于该类患者可能需要更积极地考虑口服抗凝治疗。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Liu XB, Jia ZX, Xia SJ, et al. [The thromboembolism risk of low-risk atrial fibrillation patients with different clinical characteristics]. Zhonghua Xin Xue Guan Bing Za Zhi. 2020. PMID: 32957755. doi:10.3760/cma.j.cn112148-20200306-00164

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。